Safety of long-term intrathecal methotrexate in progressive forms of MS

BACKGROUND: There are few treatment options for multiple sclerosis (MS) patients with advanced disability [expanded disability status scale (EDSS) ⩾ 6.0]. In 2010, we reported initial results of using intrathecal methotrexate (ITMTX) in patients with progressive MS. We now report on long-term use of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Neurol Disord
Asıl Yazarlar: Stark, James W., Josephs, Lena, Dulak, Deirdre, Clague, Madison, Sadiq, Saud A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6891004/
https://ncbi.nlm.nih.gov/pubmed/31832101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419892360
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller